EMA To Coordinate GMP Inspections Via Online Portal
Executive Summary
The EMA hopes that the use of a single portal by drug companies and EU/EEA inspectorates to coordinate on good manufacturing practice inspections will drive greater efficiency.
You may also be interested in...
Faster Submissions For Orphan Designation Possible As EMA’s Online Portal Goes Live
The new portal is expected to provide an improved method for applying for and managing EU orphan drug designations.
Saudi FDA Finalizes Approach To Commercial Info In Public Assessment Reports
Saudi Arabia has explained what information on a drug’s review will be made public following a marketing authorization decision.
EU Finalizes Option To Omit Expiry Date On Inner Labeling Of Investigational Drugs
Revised labeling requirements for unauthorized investigational and auxiliary medicinal products under the EU Clinical Trial Regulation have been published in the Official Journal.